Drug-Drug Interaction Study in Healthy Subjects

NCT00904059 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: BMS-650032
DRUG: BMS-790052
DRUG: BMS-650032
DRUG: BMS-790052

Sponsor

Bristol-Myers Squibb